<i><scp>EVI</scp>1</i>, a target gene for amplification at 3q26, antagonizes transforming growth factor‐β‐mediated growth inhibition in hepatocellular carcinomaKohichiroh Yasui, Yoshito Itoh, Chika Konishi et al.|Cancer Science|2015Cited by 22
General pharmacological study of talipexole, a novel agent for Parkinson's disease (2)Noritoshi OHARA, Hiroshi Nishiwaki, Y Naito et al.|Yakuri to chiryō|1993Cited by 0